Standard BioTools Inc. Common Stock LAB
i
Market dataready · fetched 2026-11-11T13:44:20.295Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-10T21:00:00.362531501Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T13:44:19.879132+00:00
Standard BioTools Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 0.51 | 796.3% | 99.2% | |||
| 25Δ | 0.58 | 763.4% | 92.1% | |||
| 30Δ | 0.65 | 730.4% | 85.0% | |||
| 35Δ | 0.73 | 697.5% | 78.0% | |||
| 40Δ | 0.80 | 664.6% | 70.9% | |||
| 45Δ | 1.04 | 572.5% | 91.6% | 0.87 | 631.6% | 63.8% |
| 50Δ | 0.97 | 604.5% | 85.3% | 0.94 | 598.7% | 56.7% |
| 55Δ | 0.89 | 636.5% | 79.0% | 1.02 | 565.8% | 49.6% |
| 60Δ | 0.81 | 668.5% | 72.6% | 1.09 | 532.8% | 42.5% |
| 65Δ | 0.74 | 700.4% | 66.3% | 1.16 | 499.9% | 35.4% |
| 70Δ | 0.66 | 732.4% | 60.0% | 1.23 | 466.9% | 28.4% |
| 75Δ | 0.59 | 764.4% | 53.6% | 1.31 | 434.0% | 21.3% |
| 80Δ | 0.51 | 796.4% | 47.3% | 1.38 | 401.1% | 14.2% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.51
- IV
- 796.3%
- B/E move
- 99.2%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.58
- IV
- 763.4%
- B/E move
- 92.1%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.65
- IV
- 730.4%
- B/E move
- 85.0%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.73
- IV
- 697.5%
- B/E move
- 78.0%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.80
- IV
- 664.6%
- B/E move
- 70.9%
45Δ
- Pseudo strike
- 1.04
- IV
- 572.5%
- B/E move
- 91.6%
- Pseudo strike
- 0.87
- IV
- 631.6%
- B/E move
- 63.8%
50Δ
- Pseudo strike
- 0.97
- IV
- 604.5%
- B/E move
- 85.3%
- Pseudo strike
- 0.94
- IV
- 598.7%
- B/E move
- 56.7%
55Δ
- Pseudo strike
- 0.89
- IV
- 636.5%
- B/E move
- 79.0%
- Pseudo strike
- 1.02
- IV
- 565.8%
- B/E move
- 49.6%
60Δ
- Pseudo strike
- 0.81
- IV
- 668.5%
- B/E move
- 72.6%
- Pseudo strike
- 1.09
- IV
- 532.8%
- B/E move
- 42.5%
65Δ
- Pseudo strike
- 0.74
- IV
- 700.4%
- B/E move
- 66.3%
- Pseudo strike
- 1.16
- IV
- 499.9%
- B/E move
- 35.4%
70Δ
- Pseudo strike
- 0.66
- IV
- 732.4%
- B/E move
- 60.0%
- Pseudo strike
- 1.23
- IV
- 466.9%
- B/E move
- 28.4%
75Δ
- Pseudo strike
- 0.59
- IV
- 764.4%
- B/E move
- 53.6%
- Pseudo strike
- 1.31
- IV
- 434.0%
- B/E move
- 21.3%
80Δ
- Pseudo strike
- 0.51
- IV
- 796.4%
- B/E move
- 47.3%
- Pseudo strike
- 1.38
- IV
- 401.1%
- B/E move
- 14.2%
Options history
No recorded observations
Medical Devices
LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures and sells therapeutic solutions globally. The company is headquartered in London, the United Kingdom.
More →LNSR
LENSAR, Inc., a commercial stage medical device company, is focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and…
More →LUNG
Pulmonx Corporation, a medical technology company, designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic…
More →MASS
908 Devices Inc. develops and sells measuring devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and Asia Pacific. The company is…
More →MBOT
Microbot Medical Inc., a preclinical medical device company, researches, designs and develops micro-robotic-assisted medical technologies targeting the minimally invasive surgery…
More →MDT
Description unavailable
More →